Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2000;2(6):430-5.
doi: 10.1186/bcr90. Epub 2000 Jul 21.

Molecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer

Affiliations
Review

Molecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer

S E Clare et al. Breast Cancer Res. 2000.

Abstract

Breast cancer mortality rates have shown only modest improvement despite the advent of effective chemotherapeutic agents which have been administered to a large percentage of women with breast cancer. In an effort to improve breast cancer treatment strategies, a variety of mathematical models have been developed that describe the natural history of breast cancer and the effects of treatment on the cancer. These models help researchers to develop, quantify, and test various treatment hypotheses quickly and efficiently. The present review discusses several of these models, with a focus on how they have been used to predict the initiation time of metastatic growth, the effect of operative therapy on the growth of metastases, and the optimal administration strategy for chemotherapy.

PubMed Disclaimer

Comment in

References

    1. Bailar JC, III, Gornik HL. Cancer undefeated. N Engl J Med. 1997;336:1569–1574. - PubMed
    1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin. 1999;49:8–31. - PubMed
    1. Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. . Lancet. 1992;339:71–85. - PubMed
    1. Brinkley D, Haybittle JL. The curability of breast cancer. . World J Surg. 1977;1:287–289. - PubMed
    1. Brinkley D, Haybrittle JL. The curability of breast cancer. . Lancet. 1975;2:95–97. - PubMed

MeSH terms

Substances